Sign in
8-K

Current Report

Acurx Pharmaceuticals, Inc. Filed Acc 0001104659-22-082266

Material agreement · Results of operations · Unregistered share sale · Code of ethics change

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.02 Results of operations and financial condition
  • Item 3.02 Unregistered sales of equity securities
  • Item 5.05 Amendment to or waiver of the code of ethics

From the SEC's structured data for this filing

Loading tm2221625d1_8k.htm…